This inventor holds 1 USPTO granted patent. Top assignee: Ichnos Sciences Sa. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Sumit Sant: Innovator in Osteoarthritis Treatment
Introduction
Sumit Sant is a notable inventor based in Thane, India. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of osteoarthritis pain. His innovative approach has led to the development of a unique compound that addresses a common yet debilitating condition.
Latest Patents
Sumit Sant holds 1 patent for his invention titled "mPGES-1 inhibitor for the treatment of osteoarthritis pain." This invention relates to a microsomal prostaglandin E synthases-1 (mPGES-1) inhibitor designed to alleviate moderate osteoarthritis pain in individuals. The method involves orally administering a substituted triazolone compound as a mPGES-1 inhibitor. Additionally, the invention encompasses pharmaceutical compositions that include the mPGES-1 inhibitor and outlines processes for preparing these compositions.
Career Highlights
Sumit Sant is currently associated with Ichnos Sciences SA, where he continues to advance his research and development efforts. His work is pivotal in creating effective treatments that improve the quality of life for those suffering from osteoarthritis.
Collaborations
Some of his notable coworkers include Monika Tandon and Neelima Khairatkar-Joshi, who contribute to the collaborative environment at Ichnos Sciences SA.
Conclusion
Sumit Sant's innovative work in developing a mPGES-1 inhibitor showcases his commitment to addressing healthcare challenges. His contributions are vital in the ongoing quest for effective treatments for osteoarthritis pain.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile